Arzneimittel – Open-House-Verträge 2026-2

  • Staat:
  • Stadt: Bremen
  • ID Ausschreibung: 20260010000271510
  • Lieferauftrag
  • Offenes Verfahren
  • Öffentliche Aufträge
  • Wirtschaftlichstes Angebot
Grundinformationen über Ausschreibung
  • Veröffentlicht: 21.04.2026.
  • Läuft ab: 01.05.2028. 23:59
  • Dokumentation zu: -
  • Preis dokumentation: -
  • Wert: -
  • Kategorien (CPV code):
                    33600000 - Arzneimittel
Die Unterlagen im Zusammenhang mit der Ausschreibung


15 Tage kostenlos



Arzneimittel – Open-House-Verträge 2026-2

Apremilast - ATC Code L04AA32; Aripiprazol - ATC Code N05AX12; Atomoxetin - ATC Code N06BA09; Bimekizumab - ATC Code L04AC21; Brodalumab - ATC Code L04AC12; Ciclosporin - ATC Code S01XA18; Colchicin - ATC Code M04AC01; Dimethylfumarat - ATC Code L04AX07; Entecavir - ATC Code J05AF10; Ertugliflozin+Sitagliptin - ATC Code A10BD24; Etanercept - ATC Code L04AB01; Formoterol, Glycopyrronium und Budesonid - ATC Code R03AL11; Fremanezumab - ATC Code N02CD03; Goserelin - ATC Code L02AE03; Ibrutinib - ATC Code L01EL01; Ixekizumab - ATC Code L04AC13; Leuprorelin - ATC Code L02AE02; Lipegfilgrastim - ATC Code L03AA14; Liraglutid - ATC Code A10BJ02; Lisdexamfetamin - ATC Code N06BA12; Macitentan - ATC Code C02KX04; Methoxy-polyethylenglycol-Epoetin beta - ATC Code B03XA03; Metronidazol - ATC Code D06BX01; Midazolam - ATC Code N03AE02; Mitomycin - ATC Code L01DC03; Octreotid - ATC Code H01CB02; Omalizumab - ATC Code R03DX05; Pegfilgrastim - ATC Code L03AA13; Peginterferon beta-1a - ATC Code L03AB13; Pimecrolimus - ATC Code D11AH02; Promethazin - ATC Code N05CM22; Pyridostigmin - ATC Code N07AA02; Rifampicin - ATC Code J04AB02; Rilpivirin - ATC Code J05AG05; Risankizumab - ATC Code L04AC18; Sofosbuvir+Velpatasvir+Voxilaprevir - ATC Code J05AP56; Somatropin - ATC Code H01AC01; Tetracyclin+Metronidazol - ATC Code A02BD08; Tiotropiumbromid - ATC Code R03BB04; Trazodon - ATC Code N06AX05; Valsartan-Sacubitril - ATC Code C09DX04; Zolmitriptan - ATC Code N02CC03



Pharmaceutical products – Open-House-Verträge 2026-2

Apremilast - ATC Code L04AA32; Aripiprazol - ATC Code N05AX12; Atomoxetin - ATC Code N06BA09; Bimekizumab - ATC Code L04AC21; Brodalumab - ATC Code L04AC12; Ciclosporin - ATC Code S01XA18; Colchicin - ATC Code M04AC01; Dimethylfumarat - ATC Code L04AX07; Entecavir - ATC Code J05AF10; Ertugliflozin+Sitagliptin - ATC Code A10BD24; Etanercept - ATC Code L04AB01; Formoterol, Glycopyrronium und Budesonid - ATC Code R03AL11; Fremanezumab - ATC Code N02CD03; Goserelin - ATC Code L02AE03; Ibrutinib - ATC Code L01EL01; Ixekizumab - ATC Code L04AC13; Leuprorelin - ATC Code L02AE02; Lipegfilgrastim - ATC Code L03AA14; Liraglutid - ATC Code A10BJ02; Lisdexamfetamin - ATC Code N06BA12; Macitentan - ATC Code C02KX04; Methoxy-polyethylenglycol-Epoetin beta - ATC Code B03XA03; Metronidazol - ATC Code D06BX01; Midazolam - ATC Code N03AE02; Mitomycin - ATC Code L01DC03; Octreotid - ATC Code H01CB02; Omalizumab - ATC Code R03DX05; Pegfilgrastim - ATC Code L03AA13; Peginterferon beta-1a - ATC Code L03AB13; Pimecrolimus - ATC Code D11AH02; Promethazin - ATC Code N05CM22; Pyridostigmin - ATC Code N07AA02; Rifampicin - ATC Code J04AB02; Rilpivirin - ATC Code J05AG05; Risankizumab - ATC Code L04AC18; Sofosbuvir+Velpatasvir+Voxilaprevir - ATC Code J05AP56; Somatropin - ATC Code H01AC01; Tetracyclin+Metronidazol - ATC Code A02BD08; Tiotropiumbromid - ATC Code R03BB04; Trazodon - ATC Code N06AX05; Valsartan-Sacubitril - ATC Code C09DX04; Zolmitriptan - ATC Code N02CC03